Foros de Conocimiento
medtronic PRODUCTOS
boston_scientific PRODUCTOS
TERUMO PRODUCTOS
Biotronik PRODUCTOS
Sirtex PRODUCTOS
Striker Neurovascular PRODUCTOS
BIOSENSORS PRODUCTOS

ESTUDIOS


28 septiembre 2015

EUROPEAN HEART JOURNAL. Sonolysis in Prevention of Brain Infarction During Carotid Endarterectomy and Stenting (SONOBUSTER): a randomized, controlled trial

David Školoudík, Martin Kuliha, Tomáš Hrbáč, Tomáš Jonszta, Roman Herzig on behalf of for the SONOBUSTER Trial Group

Aims: Previous case series have detected silent brain infarctions in as many as one-third of patients after carotid endarterectomy (CEA) and in up to two-thirds of patients after carotid angioplasty and stenting (CAS). Sonolysis employs ultrasound to facilitate disruption of thrombi and has been shown to be safe and effective for improving long-term outcomes following acute stroke. Here, we examined whether intraoperative sonolysis alters the risk of new brain ischaemic lesions during CEA or CAS.

01 noviembre 2015

JACC. Carotid Stiffness Is Associated With Incident Stroke. A Systematic Review and Individual Participant Data Meta-Analysis

Thomas T. van Sloten, Sanaz Sedaghat, Stéphane Laurent, Gérard M. London, Bruno Pannier, M. Arfan Ikram, Maryam Kavousi, Francesco Mattace-Raso, Oscar H. Franco, Pierre Boutouyrie, Coen D.A. Stehouwer

Background: Carotid stiffening is considered a key element in the pathogenesis of stroke. However, results of studies evaluating the association between carotid stiffness and incident stroke have been inconsistent.

13 septiembre 2016

STROKE. Reporting Standards for Preclinical Studies of Stroke Therapy

Farhaan Vahidy, Wolf-Rüdiger Schäbitz, Marc Fisher and Jaroslaw Aronowski

The unmet need for development of new stroke therapies is enormous. Evidence generated from positive, null, or negative preclinical studies for various therapeutic agents is crucial to enhancing scientific progress. The scientific community shares a societal responsibility to practice and promote meticulous conduct and reporting of all experimental studies. A systematic survey conducted by the UK government–sponsored National Center for the Replacement, Refinement, and Reduction of Animals in Research (NC3Rs) reported that only 59% of biomedical animal studies stated the hypotheses and objectives, and ≤87% did not use randomization.1 This, in part, led to the development of the Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines,2 modeled after the CONSORT (Consolidated Standards for Reporting Trials) statements.3

15 septiembre 2016

STROKE. Transient Cerebral Arteriopathy, Postvaricella Arteriopathy, and Focal Cerebral Arteriopathy or the Unique Susceptibility of the M1 Segment in Children With Stroke

Stéphane Chabrier, Guillaume Sébire and Joel Fluss

Like many disorders, the incidence of arterial ischemic stroke (AIS) throughout life is represented by a U-shaped curve. The peripartum period carries the highest risk, whereas people from 29 days to 18 years have the lowest risk. The incidence then gradually increases from adolescence to old age. Furthermore, the mechanisms of AIS are also age dependent. Placental–cerebral embolism is the most widely accepted hypothesis in perinatal AIS, whereas long-standing and diffuse arterial disease (namely, atherosclerosis) is the leading cause in adults.

06 septiembre 2016

STROKE. Differentiating Childhood Stroke From Mimics in the Emergency Department

Mark T. Mackay, Adriana Yock-Corrales, Leonid Churilov, Paul Monagle, Geoffrey A. Donnan and Franz E. Babl

Background and Purpose: Clinical identification of stroke in the pediatric emergency department is critical for improving access to hyperacute therapies. We identified key clinical features associated with childhood stroke or transient ischemic attack compared with mimics.

13 septiembre 2016

STROKE. Brief Screening of Vascular Cognitive Impairment in Patients With Cerebral Autosomal-Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy Without Dementia

Rebecca L. Brookes, Matthew J. Hollocks, Rhea Y.Y. Tan, Robin G. Morris and Hugh S. Markus

Background and Purpose: Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is a monogenic form of cerebral small vessel disease leading to early-onset stroke and dementia, with younger patients frequently showing subclinical deficits in cognition. At present, there are no targeted cognitive screening measures for this population. However, the Brief Memory and Executive Test (BMET) and the Montreal Cognitive Assessment (MoCA) have shown utility in detecting cognitive impairment in sporadic small vessel disease. This study assesses the BMET and the MoCA as clinical tools for detecting mild cognitive deficits in CADASIL.

13 septiembre 2016

STROKE. Speech and Language Therapy for Aphasia After Stroke. An Updated Systematic Review and Meta-Analyses

Marian C. Brady, Jon Godwin, Pam Enderby, Helen Kelly and Pauline Campbell

Introduction: Aphasia significantly affects the individual, families, and communities. Timely, effective intervention is vital. Speech and language therapy (SLT) is a complex rehabilitation intervention targeting improvement in language and communication abilities (verbal comprehension, spoken language, reading, writing), activity, and participation. Therapy may vary in intervention regimen, theoretical approach, or delivery model.

06 septiembre 2016

STROKE. Influence of Device Choice on the Effect of Intra-Arterial Treatment for Acute Ischemic Stroke in MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands)

Diederik W. Dippel, Charles B. Majoie, Yvo B. Roos, Aad van der Lugt, Robert J. van Oostenbrugge, Wim H. van Zwam, Hester F. Lingsma, Peter J. Koudstaal, Kilian M. Treurniet, Lucie A. van den Berg, Debbie Beumer, Puck S. Fransen, Olvert A. Berkhemer and for the MR CLEAN Investigators

Background and Purpose: Intra-arterial treatment by means of retrievable stents has been proven safe and effective. In MR CLEAN (Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands), the choice of the type of thrombectomy device was left to the discretion of the interventionist. The aim of this study was to explore the differences in functional outcome, neurological recovery, reperfusion, extent of infarction, and adverse events according to stent type and make.

03 septiembre 2015

STROKE. REVASCAT Trial. Further Advancement in Endovascular Stroke Therapy

Wade S. Smith and Bernard Yan

The recent REVASCAT trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within 8 Hours of Symptom Onset)1 is the latest of 5 published Prospective Randomized Open Blinded End-Point (PROBE)-designed trials of acute thrombectomy for acute, anterior circulation, large-vessel ischemic stroke serving to cap the era of equipoise for endovascular stroke therapy.2–5 The history of endovascular stroke therapy has recently been summarized.6 Following the null result of the Interventional Management of Stroke (IMS)-III trial published in 2013,7 the field transitioned to more effective removable stent (stentriever) device design8,9 and use of imaging selection (principally computed tomographic angiography with or without perfusion) rather than clinical examination. The recent 5 trials were designed around this evolution (a 6th trial has been stopped for efficacy but not yet published10).

20 agosto 2015

STROKE. Prevalence and Risk Factors of Acute Incidental Infarcts

Monica Saini, Ma Serrie P. Suministrado, Saima Hilal, Yan Hong Dong, Narayanaswamy Venketasubramanian, Mohammad K. Ikram and Christopher Chen

Background and Purpose: The study of silent stroke has been limited to imaging of chronic infarcts; acute incidental infarcts (AII) detected on brain magnetic resonance imaging have been less investigated. This study aims to describe prevalence and risk factors of AII in a community and a clinic-based population.

13 agosto 2015

STROKE. Association Between Anemia and Cerebral Venous Thrombosis. Case–Control Study

Jonathan M. Coutinho, Susanna M. Zuurbier, Aafke E. Gaartman, Arienne A. Dikstaal, Jan Stam, Saskia Middeldorp and Suzanne C. Cannegieter

Background and Purpose: Anemia is often considered to be a risk factor for cerebral venous thrombosis (CVT), but this assumption is mostly based on case reports. We investigated the association between anemia and CVT in a controlled study.

01 septiembre 2015

STROKE. Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events

Caitríona Grönberg, Eva Bengtsson, Gunilla Nordin Fredrikson, Mihaela Nitulescu, Giuseppe Asciutto, Ana Persson, Linda Andersson, Jan Nilsson, Isabel Gonçalves and Harry Björkbacka

Background and Purpose: Interleukin-16 (IL-16) functions as a regulator of T-cell growth and acts as an inducer of cell migration. The aim of this study was to determine whether IL-16 measured in human carotid plaques was associated with symptoms (eg, stroke, transient ischemic attack, or amaurosis fugax), markers of plaque stability, and postoperative cardiovascular events.

01 septiembre 2015

STROKE. Differential Vascular Pathophysiologic Types of Intracranial Atherosclerotic Stroke. A High-Resolution Wall Magnetic Resonance Imaging Study

Sookyung Ryoo, Mi Ji Lee, Jihoon Cha, Pyoung Jeon and Oh Young Bang

Background and Purpose: Intracranial atherosclerotic stroke (ICAS) has various stroke mechanisms, including branch occlusive disease (BOD), subcortical infarcts caused by parent arterial disease occluding the perforator’s orifice, and non-BOD, infarcts beyond the subcortical area caused by artery-to-artery embolism. To test whether these 2 types of ICAS had different vascular pathophysiologies, we compared the high-resolution magnetic resonance imaging characteristics between BOD and non-BOD ICAS.

25 agosto 2015

STROKE. Comparison of the 2 Most Popular Deconvolution Techniques for the Detection of Penumbral Flow in Acute Stroke

Olivier Zaro-Weber, Michelle Livne, Steve Z. Martin, Federico C. von Samson-Himmelstjerna, Walter Moeller-Hartmann, Alexander Schuster, Peter Brunecker, Wolf-Dieter Heiss, Jan Sobesky and Vince I. Madai

Background and Purpose: Dynamic susceptibility–weighted contrast–enhanced (DSC) magnetic resonance imaging (MRI) is used to identify the tissue-at-risk in acute stroke, but the choice of optimal DSC postprocessing in the clinical setting remains a matter of debate. Using 15O-water positron emission tomography (PET), we validated the performance of 2 common deconvolution methods for DSC-MRI.

11 agosto 2015

STROKE. Mannitol and Outcome in Intracerebral Hemorrhage. Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results

Xia Wang, Hisatomi Arima, Jie Yang, Shihong Zhang, Guojun Wu, Mark Woodward, Paula Muñoz-Venturelli, Pablo M. Lavados, Christian Stapf, Thompson Robinson, Emma Heeley, Candice Delcourt, Richard I. Lindley, Mark Parsons, John Chalmers and Craig S. Anderson and for the INTERACT2 Investigators

Background and Purpose: Mannitol is often used to reduce cerebral edema in acute intracerebral hemorrhage but without strong supporting evidence of benefit. We aimed to determine the impact of mannitol on outcome among participants of the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT2).

Utilizamos cookies propias para el correcto funcionamiento del sitio web y mejorar nuestros servicios. Pulse el botón Aceptar todas para aceptar su uso. Puede cambiar la configuración u obtener más información en nuestra Política de cookies o pulsando Modificar configuración.